Accenture gives its first fiscal 2027 guidance after the worst single day in its history

Upcoming catalystiThe event that could move the share price.

Accenture reports fiscal fourth quarter and full-year 2026 results on 1 October 2026, before the US market opens, with the conference call confirmed for 8:00 a.m. EDT, which is 12:00 UTC. The company announced the date on 15 September 2026. The results are published ahead of the call that morning; the exact release minute is not published in advance.

Main stock affectediThe company the event affects most directly.

Accenture plc, New York ticker ACN.

Current priceiWhere the shares traded when this write-up was made, and when that was.

$190.29 as of 17 Sept 2026, 20:00 UTC, the regular-session close.

Expected stock reactioniWhich way we expect the share price to go after the event. Positive means it rises, Negative means it falls, Mixed means it could go either way.

Negative. The positive case needs new bookings back above $20 billion and a first fiscal 2027 outlook bracketing revenue growth of 5% or better. Neither is the base case. Bookings fell 2% against last year and 13% from the record quarter before them, and the company has already guided fourth-quarter revenue to $17.75 billion to $18.4 billion against the $18.47 billion Wall Street had modelled. The negative case needs only a repeat of that, and the stock has risen 61.06% off its June low into this print, so a quarter that is merely adequate is enough to take the rally back. Guiding the first full year of a business the market now thinks artificial intelligence is dismantling is not the setup that produces a 5% growth number.

Action before the eventiWhat we suggest you do before the event. Buy, Watch or Avoid.

Watch. This is the highest-variance print on the calendar and the stock has already done most of a recovery into it. Accenture fell 17.97% in one session on 18 June 2026, the largest single-day loss in its history, and has since climbed 61.06% off the low it made four days later. Taking a position into a first annual guidance on a stock in that state is a bet on two unknowns at once. The full-year outlook is published in the release, so you can read it and act after the open on the same day.

Why the stock is affectediThe link between the event and this company.

Accenture sells consulting and managed services, and its future revenue is visible before it is earned: clients sign bookings first and the revenue arrives over the following quarters. That makes the bookings line a leading indicator and the revenue line a lagging one, which is why this stock trades on bookings and guidance rather than on the profit it just reported. The argument that has halved this company is whether generative AI shrinks the work. The bear case is that clients use Accenture to write an AI strategy and then implement it themselves with far fewer consultant hours. The bull case is that the same technology is the largest re-platforming since cloud, and that somebody has to do it. This release is where that argument gets its first full-year number attached to it.

Catalyst confidenceiHow sure we are that the event happens as described. Scored out of 100. Higher means more sure.

The event is confirmed. Accenture announced the date and the call time publicly on 15 September 2026, and a company of this size does not move its own results day. On the outcome, the fourth quarter revenue is close to settled: the company guided to $17.75 billion to $18.40 billion when it reported in June, and consensus for the quarter sits near $3.19 of earnings per share. The uncertain part is the bookings number and the first fiscal 2027 outlook. Confidence that the event happens on the date given: 97%.

Stock-reaction confidenceiHow sure we are that the stock reacts the way we expect. Scored out of 100. Higher means more sure.

Low. Realised volatility on this stock is 41.13% over 14 days and 44.78% over 50 days, which is roughly double what a consulting firm normally carries, and the last four reactions were minus 2.73%, minus 1.38%, plus 4.30% and minus 17.97%. That range is why the figure stays low even with a direction named: the size of the move is genuinely unknown, and one of those four went the other way hard. Confidence in the reaction: 45%.

When the market will reactiThe moment the price is likely to move, such as at the announcement or at the next market open.

The results come out before the US open on 1 October 2026, with the call at 12:00 UTC, ninety minutes before the bell. The tradable reaction therefore starts at the 13:30 UTC open rather than in after-hours. One detail from the last four reports is worth more than the averages. On two of them the opening print was materially worse than the close. On 18 December 2025 the stock opened 3.19% below the previous close and finished the day down only 1.38%. On 19 March 2026 it opened 4.18% below and closed up 4.30%, a swing of more than eight percentage points from the open. On this stock the opening gap has repeatedly not been the answer, and the session has been.

Effect on the businessiWhat the event changes for the company itself, such as its sales, costs or profit.

Trailing twelve-month revenue is $73.10 billion with net income of $7.79 billion, a margin of 10.66%, and free cash flow of $12.58 billion. That cash figure is the highest in the company's history and it is the fact the bear case has to argue around. What this event changes is the forward revenue estimate rather than the current one. Bookings convert to revenue over subsequent quarters, so a weak bookings number does not damage the quarter being reported; it lowers every quarter after it. That is precisely what happened in June. Third quarter revenue of $18.72 billion and earnings of $3.80 both came in fine, earnings ahead of the $3.71 expected, and the stock still had its worst day ever, because new bookings were $19.32 billion against the $20.66 billion expected and the fourth quarter guidance of $17.75 billion to $18.40 billion sat below the $18.5 billion the market wanted. Management attributed the bookings shortfall to large managed services deals slipping into fiscal 2027 for company-specific reasons. This release is where that claim is settled. If those deals were delayed, they land in this quarter or the guidance. If they were lost, they do not.

Market expectations and forecastiWhat investors already expect from this event, and the numbers being forecast.

Consensus for the fourth quarter is about $3.19 of earnings per share on revenue inside the company's own $17.75 billion to $18.40 billion guide, whose midpoint is $18.08 billion. My forecast is that the quarter itself lands broadly in line. The guidance was given ten weeks into a thirteen-week quarter and Accenture rarely misses its own revenue range. The number that decides the day is new bookings, and the number that decides the following months is the first fiscal 2027 outlook, which the company gives with its fourth quarter. For context on what that outlook has to clear: revenue grew from $64.112 billion in fiscal 2023 to $64.896 billion in fiscal 2024 and $69.673 billion in fiscal 2025, which is about 4.25% a year compounded, and the trailing figure is $73.10 billion. A fiscal 2027 range built around 5% or better would say the June bookings problem was timing. A range below 3% would say it was demand.

How much is already priced iniHow much of the expected outcome the share price already reflects before the event happens.

Medium, and the direction of that pricing has reversed twice this year. At $190.29 the shares are 34.63% below the $291.09 high struck on 14 January 2026 and 61.06% above the $118.15 low of 22 June 2026. The trailing price to earnings ratio is 15.22 and the forward ratio is 13.27, against a PEG of 2.09. Free cash flow of $12.58 billion against a market value of $116.45 billion is a free cash flow yield of 10.80%, and the dividend of $6.52 a share yields 3.43%. Those are not the multiples of a growth company and they are not the multiples of a broken one either. At the June low the market was pricing genuine structural decline. The 61.06% recovery since has priced out the worst of that, which is the part that matters for this event: the cheap-on-any-measure argument has already been partly collected, so the guidance now has to do the work rather than the valuation.

Expected price move and durationiHow far the share price may move because of this event, and how long that move may last.

Options-Implied Move I cannot confirm a current figure. The relevant expiry covering 1 October was not set when this was written, and quoting a stale straddle would be quoting a different quarter. What the chart says instead is that the average true range is already 3.18% of the price, so this stock moves more on an ordinary day than many move on results. Historical Event Analysis Measured from Polygon's daily bars. Accenture reports before the open, so the reaction is the same session's close against the previous close. Fiscal fourth quarter 2025, reported 25 September 2025: the shares fell 2.73%, from $239.08 to $232.56. Fiscal first quarter 2026, reported 18 December 2025: the shares fell 1.38%, from $273.74 to $269.96, after opening at $265.00, which was 3.19% below the previous close. Fiscal second quarter 2026, reported 19 March 2026: the shares rose 4.30%, from $195.15 to $203.55, after opening at $187.00, which was 4.18% below the previous close. That is a swing of more than eight percentage points between the open and the close. Fiscal third quarter 2026, reported 18 June 2026: the shares fell 17.97%, from $156.01 to $127.98, the largest single-day fall in the company's history, on the bookings miss described above. Historical Average Move Minus 4.44%, the average of those four. That figure is dominated by one observation and should be read as such: three of the four moves were between minus 2.73% and plus 4.30%, and the fourth was minus 17.97%. The honest summary is not that this stock falls 4.44% on results. It is that it usually moves a few percent and occasionally moves five times that. Our Expected Move Plus 6% to plus 12% if new bookings recover above $20 billion and fiscal 2027 revenue growth is guided to 5% or better. Minus 8% to minus 15% if bookings miss again or growth is guided below 3%. Two signs because this is a mixed call, and each is tied to the outcome that produces it. Bookings and the fiscal 2027 range are the switch. Both sides are wider than three of the last four reactions and narrower than the fourth. The reason is the setup. The stock has already risen 61.06% off its low, which removes some of the upside a cheap multiple would otherwise provide, and it sits 34.63% below its January high, which means a disappointment does not need to break new ground to fall a long way. Impact Strength High. This is the first full-year guidance since the market decided Accenture might be structurally impaired, and it either confirms or refutes the reason for a 59% peak-to-trough decline. Estimated Duration 1 to 3 trading days for the bulk of it. If the fiscal 2027 range settles the AI question in the company's favour, this stops being a reaction and becomes a re-rating of a stock on 13.27 times forward earnings, and that runs for weeks rather than days. None of these figures is the same claim. The historical average is what happened after the last four, the average true range is what happens on an ordinary day, and the expected move is my own conclusion drawn from both plus the guidance risk.

Result needed for a big moveiWhat the outcome has to be for the stock to move a lot instead of a little.

The earnings line will not do it. The quarter was guided in June and consensus has settled on it. What moves this stock upward is new bookings back above $20 billion together with a fiscal 2027 revenue range built on 5% growth or better, and management able to point at the specific managed services deals that slipped and say they have now been signed. That combination turns June from a demand problem into a timing problem, and on 13.27 times forward earnings with a 10.80% free cash flow yield there is a great deal of room for that to be repriced. The other side is just as specific. Bookings below $19.5 billion for a second consecutive quarter, or a fiscal 2027 revenue range implying growth below 3%, says the June explanation did not hold. On a stock that has already recovered 61.06% from its low, that is the combination that gives most of the recovery back.

Possible outcomesiThe main ways the event could turn out, with the expected stock reaction for each one.

Positive outcome. Fourth quarter revenue inside the guided range, bookings above $20 billion, and fiscal 2027 revenue guided to 5% growth or better. Expected stock reaction: a rise of 6% to 12%. This is the outcome where the market stops treating Accenture as an AI casualty. Neutral outcome. Revenue in line, bookings between $19.5 billion and $20 billion, and fiscal 2027 guided to 3% to 5% growth. Expected stock reaction: a move of 2% to 5% in either direction. This is the most likely single outcome and it settles nothing, which on this stock means the argument continues into the next quarter. Negative outcome. Bookings below $19.5 billion, or fiscal 2027 revenue growth guided below 3%. Expected stock reaction: a fall of 8% to 15%, which takes the shares back toward the levels they traded at before the summer recovery began.

Other affected stocksiOther companies that could move on the same news, such as suppliers and competitors.

IBM is the closest large read-through on enterprise consulting demand and on whether AI work is additive or substitutive. Infosys, Cognizant and Wipro are the direct offshore IT services comparisons and tend to move together with Accenture on any bookings surprise, because the bookings question is industry-wide rather than company-specific. EPAM Systems is the highest-beta name in the group and usually exaggerates whatever Accenture does. Salesforce reacts to a different half of the same argument: whether enterprises are spending on AI transformation at all.

What the market may be missingiSomething we think investors have overlooked or read wrong.

The cash has not done what the share price did, and very little attention is paid to that gap. Free cash flow was $8.996 billion in fiscal 2023, $8.615 billion in fiscal 2024 and $10.874 billion in fiscal 2025, and it is $12.582 billion on a trailing basis. It went up in three of those four periods and the trailing figure is a record. Over the same stretch the share price fell 19.64% in twelve months while the S and P 500 tracking fund rose 15.55%. That matters because a business being disintermediated usually shows it in cash before it shows it in a narrative, and this one has not. What has actually deteriorated is bookings growth, which is a forward measure and can be timing, and what has deteriorated far more is the multiple. The overlooked risk is the mirror image and it is real. Bookings lead revenue, so a company can post record cash for several quarters after its order book has turned. The June number is the first evidence for that reading, and a second weak bookings print would make the cash flow argument above look like a lagging indicator rather than a rebuttal.

What else lands that dayiOther news and events on the same day that could push the price around, and whether they help this trade, bury it, or work against it.

A moderate amount, and one thing that does not land at all. The morning is busy. Weekly initial jobless claims are published at 12:30 UTC, which is during the conference call, and the ISM manufacturing survey at 14:00 UTC, half an hour after the market opens. So the first thirty minutes of trading in this stock are a clean reaction to the results, and then a macro print lands on top of it. For a consulting company whose revenue tracks corporate confidence, ISM is not irrelevant background. 1 October is also the first day of a new quarter, which brings index and fund flows that have nothing to do with any company reporting that morning. The thing that does not land is worth stating because a reader may expect it. The US federal fiscal year ends on 30 September, and Accenture has a substantial federal services business, so a shutdown beginning on 1 October would be a direct risk to it. There will not be one. A continuing resolution was signed on 2 September 2026 funding the government at current levels through 11 December 2026. The federal risk to this stock is deferred to December, not present on the day. Net effect: the first half hour is Accenture's own, and after 14:00 UTC the move is carrying a macro print as well. Read the first thirty minutes as the verdict on the guidance, and be careful about reading the afternoon the same way.

Main risksiWhat could go wrong, and what would prove this call wrong.

The first risk is a second bookings miss. Management said the June shortfall was large deals slipping into fiscal 2027. If the same explanation is offered twice it stops being an explanation. The second is the guidance range itself. This is the first full-year number since the de-rating, and a cautious range given for ordinary prudence would be read as confirmation of the bear case whatever management says on the call. The third is that the stock has already moved. It is up 10.04% in the last month and 21.97% over three months into this print. A good result has to beat a price that has already risen in anticipation of one. The fourth is volatility itself. At 41.13% realised over 14 days, with an average true range of 3.18% of the share price, a position sized normally is a position sized wrongly here. Overall risk level: High.

Other factorsiAnything else worth knowing that the sections above do not cover.

Two things cushion the downside. The dividend is $6.52 a share, a yield of 3.43%, and it is covered roughly twice over by trailing earnings of $12.50 a share. And the company raised its planned shareholder returns by $200 million to at least $9.5 billion when it reported in June, which is a little over 8% of the current market value being returned in a single year. Neither of those stops a bad guidance number from being sold. Both of them shorten how long the selling lasts.

Trend over 6 to 12 monthsiWhich way the share price has been heading over the past year, and how far it has travelled.

Down over the year and up over the quarter, which is the whole picture in one sentence. The shares fell 19.64% over 52 weeks and 2.49% over six months, but rose 21.97% over three months and 10.04% over the last month. The 52-week range is extraordinary for a company this size: $118.15 to $291.09. The high was struck on 14 January 2026 and the low on 22 June 2026, four days after the results that caused it. The close of $190.29 on 17 September 2026 is 34.63% below the high and 61.06% above the low.

Recent price actioniWhat the shares have done over the last few weeks and sessions, and on what kind of volume.

The last three weeks contain a sharp fall and a sharper recovery. From $193.12 on 3 September 2026 the shares fell to $175.80 on 9 September, a drop of 8.97% across four sessions, including a 4.11% fall on 8 September. They then rose to $195.00 on 14 September, a gain of 10.92% in three sessions, and have since eased to $190.29. That is a stock with no settled level. Two double-digit percentage swings inside three weeks, with no company news between them, is the market arguing with itself.

Market structureiThe shape of the chart. Rising highs and rising lows mean an uptrend, falling ones mean a downtrend, and neither means the price is stuck in a range.

Neither a clean trend nor a clean range. The longer structure is lower highs from January. The shorter structure since June is higher lows, with the June low at $118.15 never revisited. Practically, the stock is rebuilding a range between roughly $175 and $197 and has spent the last three weeks crossing it twice. The 200-day average sits just above the top of that range, which makes it the level that decides which of the two structures is the real one.

Support and resistance zonesiPrice areas where buyers have stepped in before, and price areas where sellers have. They often slow the price down when it gets there again.

Below the current price the first zone is $175.49 to $179.03, the lows of 8 to 10 September 2026, tested three times in that week and held. Below that there is no tested shelf until the 50-day average at $170.15, which is 10.58% beneath the current price. Above, the first resistance is $195.00 to $197.63, the highs of 14 and 15 September 2026. The zone that matters more is the 200-day average at $200.50, 5.37% above the close, which the stock has not closed above in months. A close above $200.50 would be the first serious evidence that the June damage is being repaired. A close below $175.49 would say the recovery since June was a rebound rather than a turn.

50-day and 200-day moving averagesiThe average closing price over the last 50 days and the last 200 days. Where the price sits against them shows whether the recent trend is strong or fading.

A moving average is the average closing price over that many trading days, drawn as a line so the trend can be read without checking every session. The 50-day average is $170.15 and the 200-day is $200.50. The price is 11.84% above the 50-day and 5.09% below the 200-day, which is the arrangement a stock occupies while it is recovering: the recent trend has turned up, and the longer one has not yet. The 50-day sits $30.36 below the 200-day. That gap is the arithmetic memory of June and it will take months to close regardless of what this result says.

Relative strengthiHow this stock has performed against the wider market and against its own sector over the same period.

Mixed, and the split is informative. Over 52 weeks Accenture fell 19.64% against a 15.55% rise in the S and P 500 tracking fund, a gap of 35.19 percentage points. Over six months it fell 2.49% against a 15.30% rise, a gap of 17.79 points. Over the shorter windows it leads. Over three months Accenture rose 21.97% against 2.92%, and over the last month it rose 10.04% while the index fell 0.63%, a lead of 10.67 points in four weeks. So this is one of the weakest large-capitalisation charts of the last year and one of the strongest of the last month. Both facts are true and this event decides which one continues.

Volume trendiHow many shares are changing hands lately compared with normal. Heavy volume behind a move means more traders agree with it.

Falling, and that is the caution in the recovery. The 20-day average is 4,502,951 shares against a 50-day average of 6,035,179, so recent activity is about 25% below the heavier trade of the summer. A rally on declining volume is a rally with fewer participants. The 14 September rise of 6.04% came on 5,324,373 shares, above the recent average but below the 50-day, so even the strongest day in this recovery did not bring in the volume the June collapse did.

VolatilityiHow much the share price swings day to day right now, compared with how much it usually swings.

The 14-day average true range is $6.06, or 3.18% of the $190.29 price. The average daily high-to-low range over the last 20 sessions is $5.46, or 2.87%. Realised volatility is 41.13% over 14 days and 44.78% over 50 days, annualised. For context, those readings belong to a speculative growth stock rather than to a consulting firm, and they are the market's honest statement that it does not know what this company is worth. For sizing, a stop at one average day's range is 3.18%, and anything tighter than that will be taken out by an ordinary session, never mind by this one.

Long-Term Technical ViewiThe wider chart over years. The big trend, the major price levels and how much the stock swings.

Over several years this chart has round-tripped. The stock traded near $291 in January 2026 and near $190 now, and the multi-year support that matters is the June low at $118.15. Long-term resistance is the January high. The long-term question is not technical. A company on 13.27 times forward earnings with a 10.80% free cash flow yield is priced as though its long-term growth is close to zero, and no chart level settles whether that is right.

Technical biasiWhat the chart alone suggests, ignoring the news. Rated Bullish, Neutral or Bearish.

Neutral. Three facts hold it there rather than in either camp. The price is 11.84% above the 50-day average and 5.09% below the 200-day, which is the definition of an unresolved trend. The structure since June is higher lows, and the structure since January is lower highs, and both are intact. And the recovery has come on volume 25% below the 50-day average. This neutral chart matches the mixed call above rather than arguing with it. Neither the chart nor the catalyst view has enough to take a side, and both are waiting for the same number.

What would invalidate this biasiThe price level or chart change that would prove the technical read wrong.

A daily close above $200.50, the 200-day average, would turn the bias bullish, because it would break the run of lower highs that has defined the chart since January. A daily close below $175.49 would turn it bearish, because it would break the September lows and leave nothing tested between the price and the 50-day average at $170.15.

Technical data timestampiWhen the chart figures above were taken. Markets keep moving, so check live charts before you trade.

Every price, average, range and volume figure in this group is computed from Polygon's daily bars through the regular session that ended at 20:00 UTC on 17 September 2026. Markets move after this is written. Check a live chart before placing any trade.

Stock OverviewiThe basic numbers. Price, size of the company, sector, the past year of highs and lows, trading volume and the next earnings date.

ACN trades at $190.29 at the close on 17 September 2026. Market value is approximately $116.45 billion on 611.94 million shares. It operates in the technology sector and the IT consulting and services industry. Its 52-week range is $118.15 to $291.09. Recent average daily volume is about 4.50 million shares. Fourth quarter and full-year fiscal 2026 results are due on 1 October 2026.

What the company doesiThe business in plain words. What it sells, who buys it, and how the money reaches the company.

Accenture is hired to change how large organisations work. Clients pay it to design a strategy, then to build the systems that strategy needs, and then in many cases to run those systems afterwards. That last part is managed services, and it is the closest thing the company has to recurring revenue. Revenue arrives through contracts signed in advance, which is why the bookings figure is read before the revenue figure. A booking is work won; revenue is that work delivered, often several quarters later. The fiscal year ends on 31 August.

Revenue BreakdowniWhere the money comes from, split by product, by part of the business and by country.

Trailing twelve-month revenue is $73.10 billion. The business is reported across consulting and managed services, and across geographic markets and industry groups. I cannot confirm a precise current split by segment or by geography for the quarter being reported, so I am not quoting one. What is confirmed is the direction of the problem: the June shortfall was specifically in managed services bookings, which is the half of the business that was supposed to be the more predictable one.

Company GrowthiHow sales, profit, earnings per share and spare cash have changed over the last few years.

Reported revenue was $64.112 billion in fiscal 2023, $64.896 billion in fiscal 2024 and $69.673 billion in fiscal 2025, with $73.101 billion on a trailing basis since. That is compound growth of about 4.25% a year from fiscal 2023 to fiscal 2025, calculated as the square root of $69.673 billion divided by $64.112 billion, minus one. Net income was $6.872 billion, $7.265 billion and $7.678 billion across those years, and $7.790 billion trailing, which is about 5.70% a year compounded. Diluted earnings per share went $10.77, $11.44, $12.15 and $12.50. Company growth is Low. The rate is positive, steady and unexciting, and fiscal 2024 was almost flat on fiscal 2023. This is a large business growing in the low to middle single digits, which is exactly why the market's view of its terminal growth rate matters so much to the price.

Earnings PerformanceiThe latest results, whether they beat or missed what the market expected, and what the company says comes next.

The most recent quarter is the one that matters. In the third quarter of fiscal 2026, reported on 18 June 2026, revenue was $18.72 billion against about $18.76 billion expected and earnings per share were $3.80 against $3.71 expected. Earnings beat, revenue was a fraction light, and the stock fell 17.97%. The reason was two forward-looking lines. New bookings were $19.32 billion against $20.66 billion expected, and fourth quarter revenue was guided to $17.75 billion to $18.40 billion against the roughly $18.5 billion the market had assumed. Consensus for the fourth quarter is about $3.19 of earnings per share.

Financial HealthiCash, debt, cash flow and profit margins, and whether the company keeps issuing new shares. Rated Strong, Average or Weak.

Cash is $10.17 billion against total debt of $8.39 billion, so the company is in a net cash position. Free cash flow was $12.58 billion over the trailing twelve months, against net income of $7.79 billion, which means cash generation is running well ahead of accounting profit. Financial health is Strong. There is no scenario available in this release that creates a balance sheet problem.

ValuationiWhat you pay today for what the company earns, next to its rivals and its own past. Rated Cheap, Fair or Expensive.

The trailing price to earnings ratio is 15.22 and the forward ratio is 13.27. Enterprise value to EBITDA is 8.86 and price to sales is 1.59. The PEG ratio is 2.09. The clearest figure is the free cash flow yield. $12.58 billion of free cash flow against a $116.45 billion market value is 10.80%, which on a company with no net debt and a global blue-chip client list is a valuation normally reserved for businesses expected to shrink. Valuation is Cheap on every conventional measure. That is a statement about the multiple and not a recommendation: multiples this low on quality companies usually mean the market disputes the durability of the earnings, and here it does.

ShareholdersiWho owns the company. Big funds, company insiders, and whether ownership sits with only a few holders.

Accenture is a large-capitalisation index constituent and ownership is dominated by the major index fund managers. I cannot confirm current precise holdings percentages for individual institutions, so I am not quoting them.

Insider ActivityiWhether the people running the company have been buying or selling their own shares lately.

I cannot confirm any specific open-market insider transaction in the period covered by this card. Routine scheduled sales and equity-award activity at a company of this size should not be read as a signal in either direction.

Dividends and BuybacksiCash paid out to shareholders, whether that payment looks safe, and whether the company is buying back its own shares.

The annual dividend is $6.52 a share, a yield of 3.43%, covered roughly twice by trailing earnings per share of $12.50. That yield is unusually high for this company and is a consequence of the share price falling rather than of the dividend rising. When it reported in June the company increased planned shareholder returns by $200 million to at least $9.5 billion for the year, which is a little over 8% of the current market value. Buybacks at this multiple are considerably more valuable per dollar than they were at January's price.

Competitive PositioniWho the company competes with, how much of the market it holds, and what it has that rivals do not.

The direct competitors are IBM Consulting, Infosys, Cognizant, Wipro, Tata Consultancy Services, Capgemini and Deloitte. The advantage is scale and relationships: Accenture is embedded in a very large number of the world's biggest organisations, and being the incumbent on a system is worth a great deal when that system needs rebuilding. The vulnerability is the one the market is pricing. If generative AI reduces the hours required to deliver a project, a business that bills for expertise delivered by people has fewer hours to bill, and scale does not protect against that. Nobody yet knows whether the technology expands the work faster than it compresses the price of doing it.

Future OutlookiWhat sales and profit are expected to do next, and what management has promised.

My view on the company is neutral. Low single-digit revenue growth, record free cash flow, net cash and a covered dividend describe a durable business rather than a declining one, and nothing in the last four quarters has shown the decline the share price implies. My view on the stock is that it depends entirely on one number that has not been published yet. At 13.27 times forward earnings the market has already made a judgement about fiscal 2027, and on 1 October the company gets to answer it.

Other Upcoming Company CatalystsiOther events ahead that could move the share price, such as results, launches or approvals, apart from the catalyst this report is built on.

Fiscal first quarter 2027 results are due in December 2026, which is also when the current continuing resolution funding the US federal government expires on 11 December 2026, making that a double catalyst for a company with meaningful federal exposure. The company has continued to acquire, including recent cybersecurity purchases, and any large acquisition or a change in the pace of buybacks would move the stock outside a results day.

Long-Term Company RisksiWhat could weaken the business over the coming years, rather than around this one event.

The largest long-term risk is the one this whole card is about: that AI compresses the billable hours in technology consulting faster than it creates new work. If that is true, the current multiple is correct and the cash flow record is a lagging indicator. The second is client concentration by sector rather than by name. A large share of this business serves financial services, communications and products companies, and a downturn in corporate confidence delays discretionary transformation spending first. The third is federal exposure. The December funding deadline is a real date with a real effect on a real part of this business. The fourth is people. This is a company of hundreds of thousands of employees whose costs rise with wages and whose utilisation falls the moment bookings slow, which is what makes a bookings miss show up in margin two quarters later.

Traderavel VerdictiOur straight answer on the company after everything above, not on the trade. Quality, growth, price, risk and the long-term view.

Accenture is a high-quality business trading on a low-quality multiple, and the gap between those two facts is the entire investment case. It generates record free cash flow, holds net cash, returns more than 8% of its market value to shareholders in a year and grows revenue in the low single digits. Growth is low, financial health is strong, company risk is medium and the valuation is cheap. Long-term outlook is neutral, because the central question of whether AI grows or shrinks this business is genuinely unresolved and will not be resolved by one quarter. It suits income and value investors who can hold through a repricing and who accept that the AI argument may take years to settle. It does not suit anyone who needs low volatility: this stock has moved 17.97% in a single session this year and carries realised volatility above 41%.